使用计算方法优化帕金森病进展尺度.
Assaf Benesh1, Roy N Alcalay2,3,4, Anat Mirelman4,5
1Blavatnik School of Computer Science and Artificial Intelligence, Tel Aviv University, Tel Aviv, Israel.
NPJ Parkinson's disease
|January 23, 2026
概括
这项研究引入了一种数据驱动的方法,以改善帕金森病 (PD) 尺度. 优化的体重更好地反映了疾病的严重程度,有可能提高帕金森病研究的临床试验效率.
科学领域:
- 神经学 神经学
- 临床试验 临床试验
- 生物统计学 生物统计学
背景情况:
- 帕金森病 (PD) 是一种复杂的神经疾病,具有多种运动和非运动症状.
- 当前的临床量表,如运动障碍学会的帕金森病统一评级量表 (MDS-UPDRS),在评估疾病进展时,认为单项具有统一的重要性.
- 这种假设可能无法准确地捕捉到PD进展的异质性质.
研究的目的:
- 开发和验证一个数据驱动的方法,以优化在帕金森病研究中使用的临床尺度内的项目权重.
- 提高总评分的准确性,反映潜在疾病的严重程度和进展.
- 提高帕金森病临床试验的效率和统计能力.
主要方法:
- 对来自帕金森病进展标记计划 (PPMI) 的纵向队列数据进行了回顾性观察分析.
- 应用了新的方法来识别和加权那些最强烈地表明PD进展的项目和价值增量.
- 优化权重使用持有PPMI数据和独立数据集 (BeaT-PD) 进行了验证.
主要成果:
- 数据驱动的权重方法显著改善了总分数和临床进展之间的单调关系.
- 不那么有信息的项目被减轻或排除,导致更敏感的进展措施.
- 对独立数据集的验证证实了学习的权重的稳定性和通用性.
结论:
- 优化临床量表的权衡提供了更准确的帕金森病严重程度和进展的测量.
- 这种新的方法有可能增加临床试验中的统计能力并减少样本大小要求.
- 实施数据驱动规模优化可以促进帕金森病的研究和治疗开发.
更多相关视频
10:28Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
16.7K
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
7.4K
相关概念视频
01:15Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
01:24Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
01:24Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
01:24Parkinson Disease ll: Pathophysiology
34
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
34